Xvivo Perfusion AB (XVIVO) — Cash Flow-to-Debt Ratio
Xvivo Perfusion AB (XVIVO) has a Cash Flow-to-Debt Ratio of 0.22x as of March 2026, meaning its operating cash flow of Skr65.34 Million could theoretically repay 0% of its total liabilities (Skr299.60 Million) in one year. Explore XVIVO long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Xvivo Perfusion AB Cash Flow-to-Debt Ratio (2011–2025)
Historical debt coverage capacity for Xvivo Perfusion AB across 15 annual periods. Also explore Xvivo Perfusion AB (XVIVO) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Xvivo Perfusion AB (2011–2025)
Year-by-year debt coverage analysis for Xvivo Perfusion AB. For market capitalisation and broader financial context, see how much is Xvivo Perfusion AB worth.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.39x | Skr101.07 Million | Skr260.65 Million | ▼ -14.3% |
| 2024 | 0.45x | Skr111.29 Million | Skr245.97 Million | ▲ +144.9% |
| 2023 | 0.18x | Skr46.29 Million | Skr250.57 Million | ▲ +100.9% |
| 2022 | 0.09x | Skr27.86 Million | Skr302.95 Million | ▲ +296.1% |
| 2021 | -0.05x | Skr-12.06 Million | Skr257.15 Million | ▲ +45.8% |
| 2020 | -0.09x | Skr-12.27 Million | Skr141.85 Million | ▼ -116.7% |
| 2019 | 0.52x | Skr29.50 Million | Skr56.97 Million | ▲ +1.1% |
| 2018 | 0.51x | Skr23.63 Million | Skr46.13 Million | ▼ -21.1% |
| 2017 | 0.65x | Skr22.19 Million | Skr34.21 Million | ▲ +70.0% |
| 2016 | 0.38x | Skr12.55 Million | Skr32.88 Million | ▼ -14.1% |
| 2015 | 0.44x | Skr8.58 Million | Skr19.31 Million | ▲ +403.1% |
| 2014 | -0.15x | Skr-3.74 Million | Skr25.52 Million | ▼ -133.7% |
| 2013 | 0.44x | Skr13.46 Million | Skr30.93 Million | ▲ +571.7% |
| 2012 | 0.06x | Skr1.67 Million | Skr25.75 Million | ▼ -41.0% |
| 2011 | 0.11x | Skr14.17 Million | Skr128.97 Million | — |